Pfizer Inc
Stocks making the biggest moves midday: Ferrari, Spotify, PayPal, Palantir and more
Check out the companies making headlines in midday trading: Palantir Technologies — The software company surged 22% after reporting stronger-than-expected fourth-quarter results . Palantir attributed this earnings and revenue beat to its artificial intelligence platform gaining traction. The stock was on pace for its best day since Feb. 6, 2024, when it gained 30.8%. AMC […]
Read More
Vaccine stocks fall as Senate panel advances RFK Jr.’s nomination for HHS secretary
FILE PHOTO: Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., January 30, 2025. Nathan Howard | Reuters Shares of vaccine companies fell on Tuesday after a Senate panel […]
Read More
Stocks making the biggest moves premarket: Pfizer, PepsiCo, Palantir, Merck & more
Check out the companies making headlines before the bell. Pfizer — The pharmaceutical stock added 1.8% on better-than-expected fourth-quarter results . Pfizer reported adjusted earnings of 63 cents per share on $17.76 billion in revenue. Analysts polled by LSEG estimated earnings of 47 cents per share on revenue of $17.36 billion. PepsiCo — Shares of […]
Read More
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024. Andrew Kelly | Reuters Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company’s Covid products topped expectations and its broad cost-cutting efforts took […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Trade tailspin 2. Tariff tremor U.S. President Donald Trump speaks with members of the media as he departs the White House, in Washington, U.S., Jan. 31, 2025. Carlos Barria | Reuters Trump slapped 25% tariffs on goods from Canada […]
Read More
Reid Hoffman enters ‘wondrous and terrifying’ world of health care with latest AI startup
Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted by the Wall Street Journal at the Montage Laguna Beach in Laguna Beach, California, on October 21, 2024. Frederic J. Brown | Afp | Getty Images LinkedIn co-founder and venture capitalist Reid Hoffman became a billionaire from his business […]
Read More
Earnings playbook: Your guide to the busiest week of the season, including reports from Alphabet and Amazon
The corporate earnings season will reach its halfway point with the busiest week of the reporting period. More than 100 S & P 500 companies are slated to post their latest quarterly reports. Among those are Alphabet, Amazon and Advanced Micro Devices. So far, about 180 S & P 500 members have reported fourth-quarter earnings. […]
Read More
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on […]
Read More
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New York City after spending nearly a […]
Read More
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
U.S. President Joe Biden speaks about prescription drug costs during an event at NHTI Concord Community College in Concord, New Hampshire, U.S., October 22, 2024. REUTERS/Elizabeth Frantz Elizabeth Frantz | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off […]
Read More